Transfection Reagents and Equipment Market by Product and Geography - Forecast and Analysis 2020-2024

世界のトランスフェクション試薬&機器市場予測・分析2020-2024

◆タイトル:Transfection Reagents and Equipment Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR40213
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年11月
◆ページ数:148
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートはトランスフェクション試薬&機器の世界市場について調査・分析し、エグゼクティブサマリー、レポートの範囲、市場状況、市場規模、ファイブフォース分析、製品別(試薬、機器)分析、顧客状況、地域別状況、意思決定フレームワーク、市場の要因と課題、市場動向、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリー
・レポートの範囲
・市場状況
・市場規模
・ファイブフォース分析
・トランスフェクション試薬&機器の世界市場:製品別(試薬、機器)
・顧客状況
・地域別状況
・意思決定フレームワーク
・市場の要因と課題
・市場動向
・企業状況
・企業分析

Global Transfection Reagents and Equipment Market: About this market
Technavio’s transfection reagents and equipment market analysis considers sales from both reagents and equipment products. Our study also finds the sales of transfection reagents and equipment in Asia, Europe, North America, and ROW. In 2019, the reagents segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing commercial adoption and low prices of transfection reagents will play a significant role in the reagents segment to maintain its market position. Also, our global transfection reagents and equipment market report looks at factors such as high prevalence and incidence of cancer, improvement in healthcare infrastructure in emerging economies, and rising demand for timely disease diagnosis. However, the risk associated with the extraction of DNA and RNA, strict compliance regarding the transportation of genetically modified organisms, and intense competition among vendors may hamper the growth of the transfection reagents and equipment industry over the forecast period.

Global Transfection Reagents and Equipment Market: Overview
Rising demand for timely disease diagnosis
Early diagnosis diseases are necessary among patients with a high risk of hereditary conditions. It requires genetic tools to facilitate diagnostic tests such as next-generation sequencing and DNA microarrays. This is driving the demand for transfection reagents as they are used for conducting genetic variation testing procedures. They help in identifying risks of developing diseases such as Alzheimer’s disease, Parkinson’s disease, and cancer. Thus, the rising demand for timely disease diagnosis will lead to the expansion of the global transfection reagents and equipment market at a CAGR of over 6% during the forecast period.

Rise in clinical trials in developing nations
Transfection reagents are being increasingly used in preclinical studies as well as clinical trials to support the development of novel therapies based on the delivery of nucleic acids. Pharmaceutical companies conduct clinical trials to comply with stringent regulations and reduce their drug development costs. The rise in the number of clinical trials in developing countries can be attributed to factors such as access to a large patient pool, friendly market reforms, strong intellectual property and clinical trial infrastructure, and availability of skilled workforce. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global transfection reagents and equipment market during the forecast period 2020-2024, click here.

Competitive Landscape
With the presence of several major players, the global transfection reagents and equipment market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection reagents and equipment manufacturers, that include Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Polyplus-transfection SA, Promega Corp., QIAGEN NV, and Thermo Fisher Scientific Inc.
Also, the transfection reagents and equipment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Reagents – Market size and forecast 2019-2024
• Equipment – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Rise in clinical trials in developing nations
• Geopolitical uncertainties
• Rising healthcare expenditures
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Lonza Group Ltd.
• MaxCyte Inc.
• Merck KGaA
• Polyplus-transfection SA
• Promega Corp.
• QIAGEN NV
• Thermo Fisher Scientific Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Reagents – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Reagents – Year-over-year growth 2020-2024 (%)
Exhibit 22: Equipment – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Equipment – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Agilent Technologies Inc. – Vendor overview
Exhibit 49: Agilent Technologies Inc. – Business segments
Exhibit 50: Agilent Technologies Inc. – Organizational developments
Exhibit 51: Agilent Technologies Inc. – Geographic focus
Exhibit 52: Agilent Technologies Inc. – Segment focus
Exhibit 53: Agilent Technologies Inc. – Key offerings
Exhibit 54: Agilent Technologies Inc. – Key customers
Exhibit 55: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 56: Bio-Rad Laboratories Inc. – Product segments
Exhibit 57: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 58: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 59: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 60: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 61: Bio-Rad Laboratories Inc. – Key customers
Exhibit 62: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 63: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 64: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 65: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 66: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 67: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 68: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 69: Lonza Group Ltd. – Vendor overview
Exhibit 70: Lonza Group Ltd. – Business segments
Exhibit 71: Lonza Group Ltd. – Organizational developments
Exhibit 72: Lonza Group Ltd. – Geographic focus
Exhibit 73: Lonza Group Ltd. – Segment focus
Exhibit 74: Lonza Group Ltd. – Key offerings
Exhibit 75: Lonza Group Ltd. – Key customers
Exhibit 76: MaxCyte Inc. – Vendor overview
Exhibit 77: MaxCyte Inc. – Business segments
Exhibit 78: MaxCyte Inc. – Organizational developments
Exhibit 79: MaxCyte Inc. – Key offerings
Exhibit 80: MaxCyte Inc. – Key customers
Exhibit 81: Merck KGaA – Vendor overview
Exhibit 82: Merck KGaA – Business segments
Exhibit 83: Merck KGaA – Organizational developments
Exhibit 84: Merck KGaA – Geographic focus
Exhibit 85: Merck KGaA – Segment focus
Exhibit 86: Merck KGaA – Key offerings
Exhibit 87: Merck KGaA – Key customers
Exhibit 88: Polyplus-transfection SA – Vendor overview
Exhibit 89: Polyplus-transfection SA – Product segments
Exhibit 90: Polyplus-transfection SA – Organizational developments
Exhibit 91: Polyplus-transfection SA – Key offerings
Exhibit 92: Polyplus-transfection SA – Key customers
Exhibit 93: Promega Corp. – Vendor overview
Exhibit 94: Promega Corp. – Product segments
Exhibit 95: Promega Corp. – Organizational developments
Exhibit 96: Promega Corp. – Key offerings
Exhibit 97: Promega Corp. – Key customers
Exhibit 98: QIAGEN NV – Vendor overview
Exhibit 99: QIAGEN NV – Business segments
Exhibit 100: QIAGEN NV – Organizational developments
Exhibit 101: QIAGEN NV – Geographic focus
Exhibit 102: QIAGEN NV – Segment focus
Exhibit 103: QIAGEN NV – Key offerings
Exhibit 104: QIAGEN NV – Key customers
Exhibit 105: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 106: Thermo Fisher Scientific Inc. – Business segments
Exhibit 107: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 108: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 109: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 110: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 111: Thermo Fisher Scientific Inc. – Key customers
Exhibit 112: Validation techniques employed for market sizing
Exhibit 113: Definition of market positioning of vendors



【掲載企業】

Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Polyplus-transfection SA, Promega Corp., QIAGEN NV, and Thermo Fisher Scientific Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のトランスフェクション試薬&機器市場予測・分析2020-2024]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆